Stock KRBP KIROMIC BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Kiromic BioPharma, Inc.

Equities

KRBP

US4976342042

Delayed OTC Markets
Other stock markets
 02:19:19 2024-04-29 pm EDT 		5-day change 1st Jan Change
2.31 USD -25.00% Intraday chart for Kiromic BioPharma, Inc. -11.15% +165.52%
Apr. 24 Kiromic BioPharma, Inc. Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients CI
Apr. 02 Kiromic Biopharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kiromic Biopharma, Inc. Appoints Brian Hungerford as Chief Financial Officer
CI
Kiromic Biopharma, Inc. Announces Board Appointments
CI
Kiromic Biopharma, Inc Appoints Brian Hungerford as Interim Chief Financial Officer
CI
Kiromic BioPharma, Inc. Announces the Resignation of Dan Clark as Chief Financial Officer
CI
Kiromic Biopharma, Inc. Announces Resignation of Karen Reeves as Director
CI
Frank Tirelli Resigns His Position as Director and Member of the Audit Committee, and the Nominating and Corporate Governance Committee of Kiromic Biopharma, Inc
CI
Kiromic BioPharma, Inc. Appoints Leonardo Mirandola as Chief Scientific Officer
CI
Kiromic BioPharma, Inc. Appoints Pietro Bersani to the Role of Chief Executive Officer, Effective May 10, 2022
CI
Kiromic BioPharma, Inc. Announces Executive Changes
CI
Kiromic BioPharma, Inc. Announces Board Appointments
CI
Kiromic Biopharma, Inc Appoints Americo Cicchetti as Member of the Audit Committee of the Board
CI
Kiromic Biopharma, Inc Announces Resignation of Ignacio Nunez as Chief Manufacturing and Operating Officer I
CI
Kiromic Biopharma, Inc Announces Resignation of Jerry Schneider as Director
CI
Kiromic BioPharma : Names Interim Finance Chief
MT
Kiromic BioPharma : Names Dan Clark as Interim Chief Financial Officer After Incumbent Tony Tontat Resigns
MT
Kiromic Biopharma, Inc. Enters into an Executive Agreement with Michael Ryan to Be its Chief Technology Officer
CI
Kiromic Announces Appointment of Ignacio Núñez as Chief Operating and Manufacturing Officer
CI
Kiromic BioPharma, Inc. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KRBP Stock
  4. News Kiromic BioPharma, Inc.
  5. Insiders